ChromaDex Corporation (CDXC)

3,8000 +0,0200 (+0,53%) Al cierre: 04:00PM EDT

ChromaDex Corporation

10900 Wilshire Blvd
Suite 600
Los Angeles, CA 90024
United States
310 388 6706
https://www.chromadex.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 106

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Frank Louis Jaksch Jr.	Co-Founder & Chairman	70k	N/A	1968
Mr. Robert N. Fried	CEO & Director	768,96k	N/A	1960
Ms. Brianna Gerber	Chief Financial Officer	482,15k	N/A	1981
Dr. Andrew Shao Ph.D.	Senior Vice President of Global Regulatory & Scientific Affairs	N/A	N/A	N/A
Heather Van Blarcom	Senior VP of Legal & Corporate Secretary	N/A	N/A	N/A
Alex Worsham	Vice President of Global Marketing & Communications	N/A	N/A	N/A
Mr. David Kroes	Senior Vice President of People Matters	N/A	N/A	N/A
Ms. Chu Yan	Managing Director of Asia Pacific	N/A	N/A	N/A
Mr. Jason Campbell	Senior Vice President of Business Development	N/A	N/A	N/A
Kendall Knysch	Head of Media Relations & Partnerships	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Gobierno corporativo

El ISS Governance QualityScore de ChromaDex Corporation, a día 1 de mayo de 2024, es 5. Las puntuaciones base son Auditoría: 8; Tablero: 6; Derechos de los accionistas: 2; Compensación: 6.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.